IFIT5, similar to other IFITs, and depending on cancer types, elicits either pro-oncogenic or tumor suppressive functions depending on cancer types and can serve as either an unfavorable or favorable clinical marker (Figure 3). The gene discussed is IFIT5; the disease is neoplasm.